Physician profile
Ryan J Chatelain
NPI 1275708778
$4,246.40
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,792 · 2021: $42.45 · 2022: $278 · 2023: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $133.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imbed Biosciences INC. | $3,717.67 | 2019 | |
| Polymedics Innovations INC. | $163.71 | 2022-2023 | |
| Medtronic, INC. | $146.26 | 2022 | |
| Smith+Nephew, INC. | $60.95 | 2019-2021 | |
| Polynovo North America LLC | $44.73 | 2022-2023 | |
| Kerecis Limited | $38.14 | 2022 | |
| Osiris Therapeutics INC. | $20.80 | 2019 | |
| Abbvie INC. | $20.45 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $18.63 | 2022 | |
| Convatec INC. | $15.06 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Chatelain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.